// App-Quantinova.ai

SUN-629 : Gene Expression Networks Associated with Changes in Serum Insulin (Ins), Ins-like Growth Factor-I (IGF-I), and Growth in Growth Hormone (GH)-Treated Children with GH Deficiency (GHD)

Researchers

Presenter

  • Chiara De Leonibus

Principal Investigators

  • Benoit Destenaves

  • Maria Dolores Rodriguez-Arnao

  • Geoffrey Ambler

  • John Raelson

  • Pierre Chatelain

  • Peter Ellis Clayton

Medical Centers

  • Royal Manchester Children's Hospital, Manchester, United Kingdom

  • The Children's Hospital at Westmead, Westmead, Australia

  • Paediatric Endocrine Unit, Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Genizon BioSciences, Quebec, Canada

  • University of Manchester, Manchester, United Kingdom

  • Manchester Academic Health Science Centre, St Mary's Hospital, Manchester, United Kingdom

  • Universite Claude Bernard Lyon , EPHE, Lyon, France

Locations

  • Canada

  • Spain

  • United Kingdom

  • Australia

  • France

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Insulin

  • Insulin-like growth factor 1

Drug/Treatment

  • hGH

Outcome

  • N/A


Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim